Death receptors in chemotherapy and cancer
Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An imbalance between cell death and proliferation may result in tumor formation. Also, killing of cancer cells by cytotoxic therapies such as chemotherapy, γ-irradiation or ligation of death receptors is pr...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 April 2004
|
| In: |
Oncogene
Year: 2004, Volume: 23, Issue: 16, Pages: 2950-2966 |
| ISSN: | 1476-5594 |
| DOI: | 10.1038/sj.onc.1207558 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.onc.1207558 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/1207558 
|
| Author Notes: | Klaus-Michael Debatin and Peter H. Krammer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1750137003 | ||
| 003 | DE-627 | ||
| 005 | 20220819123612.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210302s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.onc.1207558 |2 doi | |
| 035 | |a (DE-627)1750137003 | ||
| 035 | |a (DE-599)KXP1750137003 | ||
| 035 | |a (OCoLC)1341396614 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Debatin, Klaus-Michael |d 1952- |e VerfasserIn |0 (DE-588)109442288 |0 (DE-627)507956451 |0 (DE-576)289642809 |4 aut | |
| 245 | 1 | 0 | |a Death receptors in chemotherapy and cancer |c Klaus-Michael Debatin and Peter H. Krammer |
| 264 | 1 | |c 12 April 2004 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.03.2021 | ||
| 520 | |a Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An imbalance between cell death and proliferation may result in tumor formation. Also, killing of cancer cells by cytotoxic therapies such as chemotherapy, γ-irradiation or ligation of death receptors is predominantly mediated by triggering apoptosis in target cells. In addition to the intrinsic mitochondrial pathway, elements of death receptor signaling pathways have been implied to contribute to the efficacy of cancer therapy. Failure to undergo apoptosis in response to anticancer therapy may lead to resistance. Also, deregulated expression of death receptor pathway molecules may contribute to tumorigenesis and tumor escape from endogenous growth control. Understanding the molecular events that regulate apoptosis induced by anticancer therapy and how cancer cells evade apoptosis may provide new opportunities for pathway-based rational therapy and for drug development. | ||
| 700 | 1 | |a Krammer, Peter H. |d 1946- |e VerfasserIn |0 (DE-588)121766373 |0 (DE-627)081520255 |0 (DE-576)292873417 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncogene |d London : Springer Nature, 1997 |g 23(2004), 16, Seite 2950-2966 |h Online-Ressource |w (DE-627)320469964 |w (DE-600)2008404-3 |w (DE-576)096188715 |x 1476-5594 |7 nnas |a Death receptors in chemotherapy and cancer |
| 773 | 1 | 8 | |g volume:23 |g year:2004 |g number:16 |g pages:2950-2966 |g extent:17 |a Death receptors in chemotherapy and cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.onc.1207558 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/1207558 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210302 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 121766373 |a Krammer, Peter H. |m 121766373:Krammer, Peter H. |d 50000 |e 50000PK121766373 |k 0/50000/ |p 2 |y j | ||
| 999 | |a KXP-PPN1750137003 |e 3880095418 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1750137003","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 02.03.2021"],"title":[{"title":"Death receptors in chemotherapy and cancer","title_sort":"Death receptors in chemotherapy and cancer"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Debatin, Klaus-Michael","given":"Klaus-Michael","family":"Debatin"},{"display":"Krammer, Peter H.","roleDisplay":"VerfasserIn","role":"aut","family":"Krammer","given":"Peter H."}],"relHost":[{"origin":[{"publisher":"Springer Nature ; Nature Publ. Group","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke"}],"id":{"issn":["1476-5594"],"eki":["320469964"],"zdb":["2008404-3"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"including Oncogene reviews","title":"Oncogene","title_sort":"Oncogene"}],"pubHistory":["Nachgewiesen 14.1997 -"],"part":{"year":"2004","pages":"2950-2966","issue":"16","text":"23(2004), 16, Seite 2950-2966","volume":"23","extent":"17"},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 18.03.05"],"disp":"Death receptors in chemotherapy and cancerOncogene","recId":"320469964","language":["eng"]}],"physDesc":[{"extent":"17 S."}],"id":{"doi":["10.1038/sj.onc.1207558"],"eki":["1750137003"]},"origin":[{"dateIssuedDisp":"12 April 2004","dateIssuedKey":"2004"}],"name":{"displayForm":["Klaus-Michael Debatin and Peter H. Krammer"]}} | ||
| SRT | |a DEBATINKLADEATHRECEP1220 | ||